The interview conducted by RegMedNet resulted in an article that revolves around the challenges in viral vector development and manufacturing, as well as the evolving role of viral vectors in cell and gene therapy. Natalia nicely highlights the advantages of using lentiviral vectors.

You can read the full article here:

Thanks a lot to RegMedNet for this wonderful piece!